Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in ...

UV exposure can lead to serious conditions such as cataracts, pterygium It’s quite common to experience eye strain after prolonged screen time, whether from a computer, tablet, TV, or phone.

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease. Using new ...

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

First trial of concurrent amyloid and tau immunotherapies in sporadic Alzheimer’s is underway. Safety data are a go for subcutaneous remternetug. Plaque removal correlates with cognitive benefit in ...

He was suffering from from amyloidosis, a disorder in which amyloid protein builds up in the organs. Veteran journalist Iain Finlay, 89, died by euthanasia at home. He battled amyloidosis ...

Pepoon's family took to Facebook to announce that he had been receiving treatment for a rare heart condition called cardiac amyloidosis for two years before his death on May 3. The statement read ...

Vutrisiran is currently approved in the European Union (EU) under the brand name AMVUTTRA ® for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adult patients with stage ...

Treatment modalities include liver transplantation for transthyretin-related (ATTR) amyloidosis, elimination of inflammation in amyloid A (AA) amyloidosis and intensive chemotherapy in ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.